๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
NCT07459283Maligant Solid Tumor, Head & Neck Cancer, Thyroid Cancer, Lung Cancer - Non Small Cell Squamous
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1
10
Wuxi
2026-04-20
Not yet open
A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children
NCT07511920Muscular Dystrophy, Becker, Muscular Dystrophy, Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne
West China Second University Hospital
Observational
500
Chengdu
2026-04-20
Active, closed
Procedure Manual-Based Simulation Training to Improve Operating Room Nurses' Core Competencies
NCT07527429Core Competency, Patient Safety, Interprofessional Collaboration, Surgical Outcome
Hiroshima University
Not applicable
49
2026-04-20
Recruiting
Transcutaneous Electrical Acupoint Stimulation at Jing-Well Points for Disorders of Consciousness
NCT07535593Disorders of Consciousness Due to Severe Brain Injury
Xijing Hospital
Phase 2/3
160
Xi'an
2026-04-20
Recruiting
Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease
NCT07513844Huntington Disease
First Affiliated Hospital of Fujian Medical University
Not applicable
24
Fuzhou
2026-04-20
Not yet open
GS1-144 in Participants With Hepatic Impairment and Healthy Female
NCT07491289Hepatic Impairment and Healthy Female
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
24
Changchun
2026-04-20
Not yet open
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT07583030Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE), Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD), Progressive Multiple Sclerosis (PMS), Relapsed/Refractory Myasthenia Gravis(r/r MS)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
44
Hefei, Beijing, Wuhan, Taiyuan
2026-04-20
By invitation
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression
NCT07618624Recurrent Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer
Sun Yat-sen University
Phase 2
42
Foshan, Guangzhou, Shantou, Shenzhen, Zhanjiang
2026-04-20
Not yet open
Language Function Reorganization in Patients With Arteriovenous Malformations
NCT07537504Brain Arteriovenous Malformations
Beijing Tiantan Hospital
Observational
120
Beijing
2026-04-20
Recruiting
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
NCT07483554CLDN18.2 Positive, Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
389
Hangzhou
2026-04-20
Recruiting
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07601737Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Head & Neck Cancer, Neoadjuvant Therapy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
182
Shanghai
2026-04-20
Recruiting
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
NCT07409181Systemic Lupus Erythematosus
Boehringer Ingelheim
Phase 2
405
Beijing, Changchun, Changsha, Guangzhou, Linfen, Nanjing, Ningbo, Shanghai
2026-04-20
Recruiting
Screening for Biomarkers of Osteonecrosis of the Femoral Head
NCT07545616Osteonecrosis of the Femoral Head
The First Affiliated Hospital of Xinxiang Medical College
Observational
300
Xinxiang
2026-04-20
Not yet open
Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes
NCT07520305Type 2 Diabetes
Beijing Chao Yang Hospital
Not applicable
70
Beijing
2026-04-20
Recruiting
Clinical Transformation of Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Avascular Necrosis of Femur Head
NCT07101562Avascular Necrosis of Femur Head
The First Affiliated Hospital of Xinxiang Medical College
Not applicable
30
Xinxiang
2026-04-20
Recruiting
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis๏ผˆUPRISE๏ผ‰
NCT07550673Acute Severe Ulcerative Colitis
Xijing Hospital of Digestive Diseases
Phase 4
226
Ankang, Hanzhong, Xi'an, Xianyang
2026-04-20
Not yet open
Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy
NCT07537777Hepatocellular Carcinoma (HCC), First-line Targeted Therapy Failure, Oligometastatic Hepatocellular Carcinoma, Benmelstobart
Nanfang Hospital, Southern Medical University
Phase 2
29
Guangzhou
2026-04-20
Not yet open
Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients
NCT07536607Coronary Artery Disease
Chinese PLA General Hospital
Observational
180
Beijing
2026-04-20
Not yet open
Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study
NCT07533526Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
40
Guangzhou
2026-04-20
Not yet open
Trans-round Window Membrane Intracochlear Steroid
NCT07540728Sudden Hearing Loss
Eye & ENT Hospital of Fudan University
Phase 2
108
Shanghai
2026-04-20
Recruiting
Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)
NCT07538479Solid Tumors, Solid Malignancies, Cold Exposure, Immunotherapy
West China Hospital
Phase 1
24
Chengdu
2026-04-20
Not yet open
Phase III Clinical Trial of Telitacicept Injection in the Treatment of Patients With Connective Tissue Disease-related Interstitial Lung Disease
NCT07495033CTD-ILD
RemeGen Co., Ltd.
Phase 3
260
Beijing
2026-04-20
Recruiting
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer
NCT07528209Rectal Cancer, pMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University
Phase 3
556
Guangzhou
2026-04-20
Recruiting
The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors
NCT07550907Age-related Cataract
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
300
Guangzhou
2026-04-20
Not yet open
Baduanjin Exercise on Upper Limb Dysfunction Among Breast Cancer Survivors
NCT07522593Breast Cancer Survivor
University of Southern Queensland
Not applicable
76
Zunyi
2026-04-20
Recruiting
Screening for Biomarkers of Osteoarthritis
NCT07544823Osteoarthritis (OA)
The First Affiliated Hospital of Xinxiang Medical College
Observational
300
Xinxiang
2026-04-20
Active, closed
Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)
NCT07551505Dyslipidemias
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 1
40
Beijing
2026-04-20
Recruiting
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
NCT06201013Urinary Bladder, Overactive, Overactive Bladder, Urinary Incontinence, Urge
Children's Hospital of Chongqing Medical University
Not applicable
180
Chongqing
2026-04-20
Not yet open
Artificial Intelligence (AI)-Assisted Sleep Intervention for Insomnia in Older Adults With Subjective Cognitive Decline
NCT07588035Insomnia, Sleep
The Hong Kong Polytechnic University
Not applicable
60
Qingyuan
2026-04-20
Recruiting
An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography
NCT07543263Pancreatic Cystic Lesion (PCL)
Qilu Hospital of Shandong University
Observational
176
Jinan
2026-04-20
Recruiting
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants
NCT07522970Healthy Volunteers
LinGang Laboratory
Phase 1
100
Shanghai
2026-04-20
Not yet open
The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL
NCT07548255Intermediate-to-High-Risk Mantle Cell Lymphoma, the Efficacy and Safety
Ruijin Hospital
Phase 1
28
Shanghai
2026-04-20
Recruiting
CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors.
NCT07538635High-risk R/R LBCL
Zhejiang Cancer Hospital
Phase 2
20
Hangzhou
2026-04-20
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants
NCT07476586Healthy Volunteers
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
44
Shanghai
2026-04-20
Not yet open
Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary Syndrome
NCT07543185Chronic Coronary Syndrome, Anxiety Disorder, High Ischemic Risk
Shenyang Medical College
Not applicable
214
Shenyang
2026-04-19
Recruiting
The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients
NCT07557381Schizophrenia
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Recruiting
Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia
NCT07557368Schizophrenia
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Not yet open
Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing Prediabetes
NCT07558525Prediabetes
Second Xiangya Hospital of Central South University
Not applicable
472
Quanzhou, Guangzhou, Harbin, Luoyang, Wuhan, Changde, Changsha, Loudi
2026-04-18
Recruiting
Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial
NCT07514611CHD, Overweight or Obese
Guangdong Provincial People's Hospital
Not applicable
140
Guangzhou
2026-04-18
Recruiting
Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration
NCT07554222Healthy, Active Non-segmental Vitiligo, Severe Alopecia Areata
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
160
Shanghai
2026-04-18
Recruiting
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC
NCT07416695SCLC, NEC
Shanghai Henlius Biotech
Phase 1
138
Beijing, Shanghai
2026-04-17
Recruiting
Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma
NCT07536789Hepato Cellular Carcinoma (HCC)
Fudan University
Phase 2
40
Shanghai
2026-04-17
Recruiting
QUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast Cancer
NCT07601178TNBC, Triple Negative Breast Cancer
Jiangsu Cancer Institute & Hospital
Phase 2
34
Nanjing
2026-04-17
Recruiting
LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study
NCT07556640Gastric Cancer Stage IV, Peritoneal Metastases From Gastric Cancer, Gastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital
Phase 2
74
Shanghai
2026-04-17
Not yet open
A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis
NCT07540442Dermatitis, Atopic
Shanghai Mabgeek Biotech.Co.Ltd
Phase 3
180
Shenyang
2026-04-17
Recruiting
IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07483567CLDN18.2 Positive, Primary Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
90
Beijing
2026-04-17
Not yet open
Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life
NCT07532421Antibiotic, Allergic Diseases, Infants, Probiotic
Peking University Third Hospital
Not applicable
400
Beijing
2026-04-17
Recruiting
A Retrospective Analysis of Patients With Gastroesophageal Reflux Disease Based on a Prospective Clinical Dataset
NCT07749989Gastroesophageal Reflux Disease
Beijing Friendship Hospital
Observational
5,000
Beijing
2026-04-17
Recruiting
To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07454187Relapsed/Refractory Multiple Myeloma
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1/2
40
Zhengzhou, Suzhou, Xiโ€™an, Hangzhou
2026-04-16
Recruiting
A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China
NCT07588880Progressive Familial Intrahepatic Cholestasis
Ipsen
Observational
20
Beijing, Chongqing, Hunan, Nanjing, Shanghai, Xiamen
2026-04-16
Recruiting
Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
NCT07545317Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
665
Guangzhou
2026-04-16
Recruiting
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC
NCT07235319Nasopharangeal Cancer, Distant Metastasis
Sun Yat-sen University
Phase 3
260
Guangzhou, Changsha, Fuzhou, Hangzhou, Nanning
2026-04-16
By invitation
Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis
NCT07652372Knee Osteoarthritis
ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
Phase 1
60
Beijin, Shijiazhuang
2026-04-16
Recruiting
Evaluation of the Efficacy and Safety of Darolutamide + ADT Combined With Low-dose Docetaxel in mHSPC
NCT07503379mHSPC
Yonghong Li
Phase 2
109
Guangzhou, Meizhou
2026-04-16
Recruiting
Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage โ… -โ…ก MALT Lymphoma
NCT07554898MALT Lymphoma
Zhejiang Cancer Hospital
Phase 2
60
Hangzhou
2026-04-16
Not yet open
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma.
NCT07539233Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1
24
Tianjin
2026-04-15
Recruiting
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
NCT07158242Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche
Phase 3
100
Hangzhou, Shanghai
2026-04-15
Recruiting
Picankibart in Palmoplantar Pustulosis
NCT07552454Palmoplantar Pustulosis
Xijing Hospital
Not applicable
60
Xi'an
2026-04-15
Not yet open
A Exploratory Study on Untreated Follicular Lymphoma With Orelabrutinib, Tafasitamab, and Lenalidomide
NCT07585747Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
27
Shenzhen, Zhengzhou, Nanchang, Jinan, Tianjin
2026-04-15
Recruiting
Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer
NCT07704177Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital
Phase 2
70
Beijing
2026-04-15
Recruiting
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
NCT07385703Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
752
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-04-15
Not yet open
Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies
NCT07485504Relapsed or Refractory Hematologic Malignancies
Tcelltech Inc.
Phase 1
15
Tianjin
2026-04-15
Not yet open
Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients
NCT07483671Bacterial Vaginosis
Chengdu Syncor Pharmaceutical Co., Ltd.
Phase 2
80
Tianjin
2026-04-15
Not yet open
The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device
NCT07514949Stroke, Acute Ischemic Stroke, Blood-Brain Barrier
yilong Wang
Not applicable
6
Beijing
2026-04-15
Recruiting
VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial
NCT07514832AML (Acute Myeloid Leukemia)
Beijing 302 Hospital
Phase 2
48
Beijing
2026-04-15
Not yet open
A Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Replacement for Type-0 Bicuspid Aortic Valve Stenosis Patients in China
NCT07450196Aortic Stenosis, AORTIC VALVE DISEASES
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
170
Beijing
2026-04-15
Not yet open
Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging
NCT07554742Pancreatic Cancer, Gastric Cancer, Gastroesophageal Junction Cancer
Ruijin Hospital
Observational
64
Shanghai
2026-04-15
Recruiting
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
NCT07412613Resectable Colon Cancer, MSI-H/dMMR Colorectal Cancer
Akeso
Phase 3
386
Guangzhou
2026-04-15
Not yet open
Using Real-Time Lung Visuals to Reduce Mental Strain and Improve Diagnosis Speed
NCT07511712Mechanical Ventilation, Clinical Competence, Education Curriculum, Self Concept
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
34
Hangzhou
2026-04-15
Not yet open
An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
NCT07528040Crohn's Disease (CD)
Shanghai 10th People's Hospital
Observational
88
Shanghai
2026-04-15
Recruiting
Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis
NCT07542938Symptomatic Intracranial Atherosclerotic Stenosis
Xuanwu Hospital, Beijing
Not applicable
264
Beijing, Fuzhou, Shijiazhuang, Harbin, Nanyang, Zhengzhou, Baotou, Xi'an
2026-04-15
Recruiting
Becotatug Vedotin Plus Pucotenlimab and Platinum Chemotherapy in Locally Advanced Epidermal Growth Factor Receptor (EGFR)-Positive Head and Neck Squamous Cell Carcinoma
NCT07814287Head and Neck Squamous Cell Carcinoma, HNSCC
Xuekui Liu
Phase 2
40
Guangzhou
2026-04-15
Recruiting
Effects of Opioid Drugs on Sleep and Emotion in Patients With Moderate to Severe Cancer Pain
NCT07616648Moderate to Severe Cancer Pain
First Affiliated Hospital of Zhejiang University
Observational
200
Hangzhou
2026-04-15
Not yet open
Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:
NCT07542288Brain Metastases From Solid Tumors
The Second Affiliated Hospital of Hainan Medical University
Phase 2/3
400
Haikou
2026-04-15
Recruiting
Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors
NCT07482592Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
156
Tianjin
2026-04-15
Recruiting
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
NCT07463248Hepatocellular Carcinoma (HCC)
Wang Xin
Phase 2
64
Chengdu
2026-04-15
Not yet open
Efficacy of Multi-Type Photolithography Flat Microstructure Lenses for Childhood Myopia Control
NCT07535658Myopia
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
255
Shanghai
2026-04-15
By invitation
Effects of Transcranial Temporal Interference Stimulation on Cognitive Function in Mild Cognitive Impairment
NCT07519798Mild Cognitive Impairment (MCI)
Shanghai University of Sport
Not applicable
40
Shanghai
2026-04-15
Recruiting
Corticosteroids in Hyperinflammatory Phenotype of Critical Illness
NCT07511582Sepsis, Acute Respiratory Distress Syndrome
Bin Du
Phase 2
150
Beijing
2026-04-15
Recruiting
Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II
NCT07396077Spine Degeneration, Lumbar Degenerative Disease, Frail Elderly, Enhanced Recovery After Surgery (ERAS) Protocol
Xuanwu Hospital, Beijing
Not applicable
248
Beijing
2026-04-15
Recruiting
Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)
NCT07496229T-cell Lymphomas
Dizal Pharmaceuticals
Phase 1/2
165
Chongqing, Fuzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Chengdu, Taizhou
2026-04-15
Active, closed
AI-Assisted Mindfulness Intervention in Emotional Distress
NCT07542561Subclinical Depression, Subclinical Anxious Adults, Subclinical Emotional Distress
Xinghua Liu
Not applicable
550
Beijing
2026-04-15
Recruiting
A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma
NCT07478302Advanced Unresectable Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
36
Fuzhou, Nanning
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
NCT07533006Alopecia Areata
Eli Lilly and Company
Phase 2
60
Beijing, Shanghai, Tianjin
2026-04-14
Recruiting
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07493135Relapsed/Refractory Multiple Myeloma
Suzhou Immunofoco Biotechnology Co., Ltd
Phase EARLY_PHASE1
30
Beijing, Chongqing, Shanghai, Zhengzhou
2026-04-14
Recruiting
Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors
NCT07759960Rectal Neuroendocrine Tumor
Nanfang Hospital, Southern Medical University
Not applicable
174
Guangzhou
2026-04-14
Recruiting
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
NCT07525986Laparoscopic Surgery, Visceral Pain, Postoperative, Anrikefon, Patient-controlled Intravenous Analgesia
Peking University First Hospital
Phase 4
140
Beijing
2026-04-14
Recruiting
Efavirenz for the Treatment of Creutzfeldt-Jakob Disease
NCT07482085Creutzfeldt-Jakob Disease
Xuanwu Hospital, Beijing
Phase 3
246
Beijing
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
Eli Lilly and Company
Phase 2
66
Beijing, Hangzhou, Shanghai, Shenzhen
2026-04-14
Active, closed
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
NCT07663903Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
60
Tianjin, Fuyang, Fuzhou, Ganzhou, Guangzhou, Hefei, Huai'an, Jinan
2026-04-14
Recruiting
Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors
NCT07529002Solid Tumors
Peking University Cancer Hospital & Institute
Observational
20
Beijing
2026-04-14
Recruiting
CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms
NCT07416682High-risk Plasma Cell Neoplasms
Affiliated Hospital to Academy of Military Medical Sciences
Phase EARLY_PHASE1
20
Beijing
2026-04-14
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
NCT07541521Stage IIB-III NSCLC, Sleeve Lobectomy, Robotic Surgery, Neoadjuvant Chemoimmunotherapy
Shanghai Chest Hospital
Observational
100
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-04-13
Recruiting
Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
NCT07439120Urothelial Carcinoma (UC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
10
Shanghai
2026-04-13
Recruiting
Acupuncture Therapy for Sudden Sensorineural Hearing Loss
NCT07575334Sudden Sensorineural Hearing Loss (SSNHL)
Eye & ENT Hospital of Fudan University
Not applicable
256
Shanghai
2026-04-13
Recruiting
A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants
NCT07443059Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
40
Xiamen, Jinan, Chengdu
2026-04-13
Recruiting
DAREON ยฎ -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim
Phase 3
670
Beijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2026-04-13
Recruiting
Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules
NCT07507838Healthy Volunteers
Vigonvita Life Sciences
Phase EARLY_PHASE1
24
Hefei
2026-04-13
Not yet open
The Selective Intraperineural Nerve Root Block Study
NCT07531485Radiculopathy Lumbar, Radiculopathy Sacral, Radiculopathy Multiple Sites, Herniated Disc
Xi'an Honghui Hospital
Not applicable
80
Xi'an
2026-04-13
Recruiting
A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism
NCT07540286Hypoparathyroidism
Peking Union Medical College Hospital
Phase 2
60
Beijing
2026-04-13
Rows per page Showing 2701–2800 of 19052
Previous 26 27 28 29 30 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=28

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.